Claros Mortgage Trust, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Claros Mortgage Trust, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $187.83M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $248.42M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $306.55M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $287.20M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $262.66M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $273.71M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $249.61M | Mar 16, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($489.07M) | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | ($221.27M) | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $6.03M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $112.16M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $161.16M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $194.56M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $163.17M | Mar 16, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($30.46M) | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $84.52M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $111.14M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $111.03M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $213.56M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $140.50M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $129.55M | Mar 16, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.72B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $6.97B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $8.07B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $8.24B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $7.46B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $6.95B | Mar 16, 2022 |
| FY2021 | Dec 31, 2019 | $6.55B | Mar 16, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.19B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $4.96B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $5.77B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $5.79B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $4.85B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $4.33B | Mar 16, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $2.46B | Feb 16, 2023 |
| FY2022 | Dec 31, 2021 | $2.57B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $2.45B | Mar 16, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.22B) | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | ($733.32M) | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | ($426.70M) | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | ($257.25M) | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | ($160.96M) | Feb 16, 2023 |
| FY2021 | Jan 1, 2021 | $78.25M | Mar 16, 2022 |
| FY2021 | Dec 31, 2020 | $526.21M | Mar 16, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $173.19M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $99.08M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $187.30M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $306.46M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $310.19M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $427.51M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $335.00M | Mar 16, 2022 |
| FY2021 | Dec 31, 2018 | $69.43M | Mar 16, 2022 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.16B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $4.90B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $5.69B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $5.69B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $4.76B | Feb 16, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (3) | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Mar 16, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (3) | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Mar 16, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 140.22M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 139.36M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | 138.75M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | 138.38M | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | 139.84M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | 125.54M | Mar 16, 2022 |